The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amaryl 3 mg tablet

3 milligram(s) Tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/028/003

Main Information

Trade NameAmaryl 3 mg tablet
Active SubstancesGlimepiride
Strength3 milligram(s)
Dosage FormTablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/028/003

Group Information

ATC CodeA10BB Sulfonamides, urea derivatives
A10BB12 glimepiride


Licence Issued29/11/1996
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back